This edition of International Heart Congress has already taken place.

Search future editions →

Events Healthcare & MedTech

Healthcare & MedTech

International Heart Congress 2025

Trade-orientedBoutiqueHybridInternational draw
📅 5 June 2025 – 7 June 📍 NH Villa Carpegna, Rome, IT ↗ 🏢 Magnus Group 🔁 annual

An international academic congress focused on clinical cardiology, cardiac surgery, and cardiovascular research, bringing together healthcare professionals to share advancements in patient care and medical technology.

Healthcare ServicesMedical Devices cardiologycardiac surgerycardiovascular researchheart healthmedical technologypatient care

Filter this event to your ICP.

Hundreds of exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.

Request intelligence →

Delivery within 24 hours · $1,250

⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.

Venue

NH Roma Villa Carpegna

Conference centre · 1,059 m² · 12 halls · ~350 people

A 4-star conference hotel located in a quiet area of Rome, featuring 201 guest rooms and 12 meeting rooms. The venue offers extensive meeting facilities, including a plenary room with a capacity for 350 people, suitable for conferences, business events, and exhibitions.

📍 Via Pio IV, 6, 00165 Roma RM, Italy

Operated by NH Hotel Group

13 events tracked at this venue → Venue website ↗

Organizer

Magnus Group

Private · Herndon, United States · Founded 2012

An international event manager organizing scientific, medical, and engineering conferences and seminars globally.

Runs 30 events → LinkedIn ↗

Why people attend

Healthcare professionals attend to evaluate new cardiovascular technologies, cardiac diagnostic equipment, and surgical instruments while participating in scientific knowledge exchange.

Who attends

Cardiologistscardiac surgeonsmedical researchershealthcare professionalsand academic scholars specializing in cardiovascular medicine.

Exhibitor categories

Medical DevicesCardiovascular EngineeringPharmaceuticalsClinical Trial Sites

Sample matches

Filtered to a Series-B SaaS ICP. Your filter will be different.

Sample Match A

example.com

91 — High
Enterprise SaaS200–500 employeesAmsterdam, NL

"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."

Sample Match B

example.io

79 — Medium
Cloud platform50–200 employeesLondon, UK

"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."

████████ ██████

████████.io

██ — Medium
████████████ 200–500 employees ████, ██

"████████████████████████████████████████."

Submit your ICP
to unlock all matches

Request intelligence →

████████ ██████

████████.io

██ — Medium
████████████ 200–500 employees ████, ██

"████████████████████████████████████████."

Submit your ICP
to unlock all matches

Request intelligence →

Speakers

239 speakers at International Heart Congress

H

Hannah Visser

Medical Student · William Carey University College of Osteopathic Medicine

"Assessing quality of content on TikTok: Postural orthostatic tachycardia syndrome"

Bio

Hannah Visser graduated from Michigan State University with a Bachelor of Science in Human Biology in 2022. Currently, a third-year medical student at William Carey University College of Osteopathic Medicine, Hannah Visser is passionate about pursuing a career in internal medicine.

POTSsocial media in medicinecardiology
R

Ryan Slaughenhaupt

University of Cincinnati College of Medicine

"Safety and outcomes of cardiopulmonary resuscitation in patients with left ventricular assist devices"

Bio

Ryan Slaughenhaupt studied Biological Sciences at Dartmouth College, USA and graduated with a BA in 2021. He then began medical school at the University of Cincinnati College of Medicine, USA in 2022.

cardiopulmonary resuscitationleft ventricular assist devicescardiology
A

Afrasayab Khan

Central Michigan University

"Comparative outcomes of mitraclip therapy versus surgical and conservative management for mitral regurgitation: A meta-analysis"

Bio

Michigan University (CMU), Michigan, with a keen interest in cardiology. His research focuses on valvular heart disease, interventional cardiology, and role of AI and emerging technologies in structural heart interventions. Dr. Khan has presented his work at several prestigious cardiology conferences, including the American College of Cardiology (ACC), American Heart Association (AHA), Transcatheter Cardiovascular Therapeutics (TCT), and the Society for Cardiovascular Angiography and Interventions (SCAI). He continues to contribute to the field through clinical research and collaborative efforts.

cardiologymitral regurgitationcoronary revascularization
K

Kalpesh Patel

Highly Specialist Cardiac Pharmacist · Barts Health NHS Trust

"The management of hypercholesteremia with lipid lowering therapy inclisiran"

Bio

Mr Kalpesh Patel studied Pharmacy in Kingston University London and graduated with a MPharm degree in 2013. He then joined Barts Health NHS Trust to complete his GPhC pre-registration training. He is currently working as a highly specialist cardiac pharmacist at St Bartholomew’s Hospital in London, a tertiary referral center for cardiovascular medicine as part of Barts Health NHS Trust. Kalpesh is the lead pharmacist for cardiothoracic surgery and is part of the CVD Risk Prevention and Lipid clinic, with a specialist interest in acute coronary syndrome and lipid management. He has published various articles in the Pharmaceutical Journal supporting cardiovascular disease and management.

hypercholesteremialipid lowering therapycardiology
C

Claudio Soto

Senior Perfusionist · St Vincent's Hospital

"A decade of DCD heart transplantation utilising normothermic machine perfusion in Australia"

Bio

Claudio Soto graduated from the University of Sydney in 1994 with an MSc, and is a Senior Perfusionist at St Vincent’s Hospital Sydney, being there for the last 26 years. Being the Senior DCD Heart Retrieval and MCS Perfusionist, he plays a valuable role in the retrieval, preservation and assessment of DCD hearts and had a significant role in the world's first DCD heart transplantation in 2014. He’s also involved with hypothermic machine perfusion, as well as ECMO and eCPELLA retrieval programs both domestic and internationally and is heavily involved in ongoing heart preservation research with the units Large Animal Laboratory.

DCD heart transplantationnormothermic machine perfusionheart preservation
R

Roselyn Oyenug

Obstetrics and Gynecology Resident · University of Connecticut

"Baseline cardiac status in pregnant patients with sickle cell disease"

Bio

Dr. Oyenuga earned a Bachelor’s degree in Exercise Science from Florida State University in 2014, followed by a master’s degree in Medical Sciences from the University of South Florida in 2017. Following graduation, she worked in clinical research in the Department of Gynecologic Oncology. She received her medical degree from the Alabama College of Osteopathic Medicine in 2022. Dr. Oyenuga is currently a third-year Obstetrics and Gynecology resident at the University of Connecticut. Her research focuses on improving maternal and fetal outcomes in patients with sickle cell disease.

sickle cell diseasematernal healthcardiology in pregnancy
N

Neda Najafimakhsoos

University of Bologna

"Periodontal and cardiovascular disease: Shared pathophysiology and therapeutic implications – New insights for 2025"

Bio

Neda Najafimakhsoos graduated with highest honors from the University of Bologna in October 2022, receiving the award for Best Academic Performance. Passed the INBDE in 2024 and is completing a Master’s degree in Orthodontics and Endodontics in 2025. Deeply interested in the systemic implications of oral health, with focused knowledge in periodontitis, oral surgery, and endodontics in relation to systemic disease. Actively participates in relevant conferences and has presented multiple scientific posters on these topics.

periodontal diseasecardiovascular diseaseoral health
A

Agustin Joison

Professor and Researcher · Cordoba Catholic University

"Arterial and venous thrombolysis with a new modified JG microplasmin"

Bio

Agustin Joison is a biochemist who graduated from the National University of Córdoba in 1980. In 2003, he received his master's degree in health services management and earned his doctorate in health sciences in 2017. Since 1994, he has served as a professor and researcher at the Catholic University of Córdoba. He has published 25 articles and participated in several conferences. In 2007, he obtained a patent for the development of a fibrinolytic protein.

thrombolysiscardiovascular medicinebiochemistry

Also speaking at 7th Edition of Cardiology World Conference

A

Armele Dornelas de Andrade

Full Professor · Federal University of Pernambuco

"Association between endothelial dysfunction assessed by Reactive Hyperemia Index (LnRHI) and diabetes mellitus in heart transplant recipients"

Bio

Dr. Armele Dornelas de Andrade is a Full Professor at the Federal University of Pernambuco (UFPE), Brazil. She holds degrees in Physiotherapy and Physiology from UFPE and a Ph.D. in Pneumoalergology from Université d'Aix-Marseille III, France, with postdoctoral training at the University of British Columbia, Canada. Her research focuses on respiratory physiology and physiotherapy, particularly aerosol therapy and respiratory muscle function. She has published over 160 scientific articles, 17 book chapters, and has an h-index of 29. Dr. Andrade actively mentors graduate students and collaborates internationally, being a member of the International Society of Aerosols in Medicine and the European Respiratory Society.

cardiologydiabetesheart transplant
M

Maria da Gloria Rodrigues Machado

Professor of the Post-Graduate Program in Health Sciences · Faculty of Medical Sciences of Minas Gerais

"Determinants of arterial compliance and vascular resistance in healthy children and adolescents; Association of arterial stiffness and changes in intrinsic capacity through the locomotion domain in elderly people in primary care"

Bio

Post-doctorate from Harvard Medical School-Anesthesia Center for Critical Care Research, MGH. Master's, Doctorate and Post-doctorate in Biological Sciences (Physiology and Pharmacology) from the Federal University of Minas Gerais. Professor of the Post-Graduate Program in Health Sciences at Faculty of Medical Sciences of Minas Gerais, in the research field of Sciences Applied to Cardiovascular Diseases. Has experience in physiology and pathophysiology of cardiovascular diseases with emphasis on blood arterial pressure and the renin-angiotensin system. Leader of the research group "Pathophysiology, evaluation and intervention in respiratory and cardiovascular diseases". Collaborator of the Youth Vascular Consortium (Baker Heart and Diabetes Institute, Melbourne, Australia).

cardiovascular diseasesarterial stiffnesspediatric health
Y

Yin Xiaoyang

Master's degree student in Clinical Chinese Pharmacy · Beijing University of Chinese Medicine

"Exploring the pathological connection and clinical management of hyperuricemia and atherosclerosis: A literature review-based investigation"

Bio

Yin Xiaoyang, graduated from Jilin Institute of Agricultural Science and Technology with a Bachelor's degree, is currently a Master's degree student in Clinical Chinese Pharmacy, studying at Beijing University of Chinese Medicine, with a research interest in Chinese medicine to prevent and treat metabolic diseases.

hyperuricemiaatherosclerosismetabolic diseases
U

Uwe Peter Tigor

Auxilius Pharma

"Current approaches to anti-angina drug treatment in Chronic-stable Angina Pectoris (CSAP) in US primary care and cardiology – A cross-sectional, blinded standard-of-care survey"

Bio

Tigör trained both in Germany and the US and earned his medical degree from Charité School of Medicine of Humboldt University, in Berlin, Germany. He spent several years in cardiovascular research including a research fellowship at Mount Sinai Hospital in New York, In 2019, he co-founded Auxilius Pharma, a Warsaw based biotech startup focusing on developing new, innovative treatment options for cardiovascular conditions with high unmet need such as chronic-stable angina.

cardiovascularchronic-stable anginaanti-angina drug treatment
H

Hui Geng

Young Physician for the American Heart Association, Director of the Chinese Hypertension League · Peking University First Hospital

"Cardiovascular outcomes in initial and sustained orthostatic hypotension: A retrospective cohort study"

Bio

Dr. Geng studied Clinical Medicine at Peking University Health Science Center and received her MD degree in 2014. She currently serves as a young physician for the American Heart Association and as a director of the Chinese Hypertension League. She has participated in and led numerous scientific research projects. She has published many research articles in SCI (E) journals and participated in the compilation of multiple books.

orthostatic hypotensioncardiovascular outcomesretrospective cohort study
M

Muhammad Wasim Sajjad

Registrar in Cardiac Surgery · Rehman Medical Institute

"Comparison of autologous vs non-autologous blood transfusion in patients undergoing coronary artery bypass grafting surgery"

Bio

Dr. Muhammad Wasim Sajjad, completed his MBBS from Ayub Medical College, Abbottabad, followed by a two-year General Surgery training at Lady Reading Hospital (LRH), Peshawar. Then he joined Rehman Medical Institute (RMI) for Cardiac Surgery, where he successfully completed a three-year residency. Currently, He is working as a Registrar in Cardiac Surgery at RMI. He has several published research papers and has presented his work at various national conferences, reflecting his commitment to advancing the field of cardiac surgery.

cardiac surgeryblood transfusioncoronary artery bypass grafting
T

Tamer Moustafa

Professor of Cardiology & Intervention · Zagazig University

"Prevalence of microvascular dysfunction in patients with heart failure with preserved ejection fraction : Angiographic pararmeters"

Bio

Tamer Moustafa has a medical degree (M.B.B.Ch.) from Zagazig University and completed house officer and cardiology residency in the same university hospitals from 1997-2001. He have a Master's degree in Cardiology and completed a fellowship of coronary intervention in Paris in 2004. He later completed an M.D. in Cardiology and became an Assistant Professor of Cardiology at Zagazig University. He currently hold the position of Professor of Cardiology & Intervention. He have 22 years of experience in echocardiography and are an interventional cardiologist with a specialization in coronary intervention, including primary PCI, and skills in dealing with IABP, pacemakers, IVUS & FFR. Tamer Moustafa also have specific training in congenital echocardiography and IVUS. He was previously an instructor in the European Advanced Life Support and Egyptian Echocardiography for Congenital Echocardiography. He is the founder of the Sharkia Cardiac Association group and an executive member of the Egyptian Atherosclerosis and Vascular Biology (EAVA).

heart failuremicrovascular dysfunctionangiography
A

Amitabh Satsangi

Assistant Professor · AIIMS

"Minimally invasive cardiac surgery in congenital heart diseases: The new horizon"

Bio

Dr Amitabh Satsangi currently working as assistant professor in department of CTVS AIIMS, New Delhi. Did MS (Gen Surgery) From GSVM Medical college in 2018 with Honours, MCh Cardiovascular and thoracic surgery from AIIMS New Delhi with first rank. Selected as Thoracic Surgery Foundation SAHA scholar in 2020. Has published many articles in various national and international journals.

minimally invasive cardiac surgerycongenital heart diseasespediatric cardiac surgery

+ 223 more speakers at this event.

More Healthcare & MedTech events

Healthcare & MedTech

Pharma Manufacturing World Summit

Boston, US May 2027

Healthcare & MedTech

REHAB

Karlsruhe, DE May 2027

400 exhibitors

Healthcare & MedTech

Vitafoods Europe

Barcelona, ES May 2027

1,600 exhibitors

Healthcare & MedTech

World Vaccine Congress Washington

Washington D.C., US Mar 2027

More Healthcare & MedTech events

All Healthcare & MedTech trade showsAll events in Italy

Frequently asked questions

When is International Heart Congress?+
International Heart Congress takes place on 5 June 2025 to 7 June 2025.
Where is International Heart Congress held?+
International Heart Congress is held at NH Villa Carpegna, Rome, IT.
Who organises International Heart Congress?+
International Heart Congress is organised by Magnus Group.
How often is International Heart Congress held?+
International Heart Congress is held annual.

Ready to map International Heart Congress?

Request intelligence →